Latest news about Max Healthcare Institute
Max Healthcare plans to expand capacity by around 8,300 beds
Max Healthcare Institute
986.40
-4.10(-0.41%)
Company Performance:
View Company Insights1D-0.41%
1M-8.70%
6M-9.20%
1Y-19.24%
5Y+203.23%
More news about Max Healthcare Institute
13Aug 26
Max Healthcare Q1 revenue up 17% to ₹23.7B; net profit misses estimate
Max Healthcare Institute posted Q1 revenue of ₹23.7 billion, up 17% from ₹20.2 billion last year. Net profit increased slightly to ₹3.2 billion from ₹3.1 billion but fell short of the ₹4 billion analyst estimate. EBITDA grew to ₹5.98 billion, though margins dipped to 25.3% from 25.8%. The company also secured approval to set up medical colleges.
13Aug 26
Max Healthcare NRC approves 3,61,827 employee stock options
Max Healthcare Institute’s NRC approved 3,61,827 stock options under the 2022 scheme. Grants include 1,61,827 options at ₹800 and 2,00,000 options at ₹350. Vesting occurs over one to five years, with a three-year exercise window post-vesting.
10Aug 26
Max Healthcare Institute Sees ₹15.19 Crore Block Trade on NSE at ₹1,067.30 Per Share
Max Healthcare Institute recorded a block trade on the NSE involving approximately 1,42,335 shares at a price of ₹1,067.30 per share. The total value of the transaction stood at ₹15.19 crores. Block trades of this scale are generally associated with institutional or bulk investor activity and are closely tracked by market participants.
08Aug 26
Max Healthcare Q1 Results: Earnings call scheduled for Aug 14
Max Healthcare Institute Limited has scheduled an earnings call for August 14, 2026, to discuss Q1FY27 results. The results for the quarter ended June 30, 2026, will be declared on August 13. Management will discuss operational highlights and answer investor questions via a registered conference call.
08Aug 26
NCLT allows rectification in Max Healthcare legal dispute
Max Healthcare Institute Ltd informed stock exchanges that the NCLT, Cuttack Bench, allowed the opposing party to rectify a procedural defect in an affidavit during hearings on August 4, 2026. The case involves petitions by legal representatives of BRS Capital Two Pte. Limited against the company and its subsidiary, Kalinga Hospital Ltd. The matter is listed for further consideration on August 19, 2026.
07Aug 26
Max Healthcare files 25th AGM minutes, confirms ₹2 dividend and office shift
Max Healthcare Institute Limited confirmed via AGM minutes filed on August 6, 2026, that shareholders approved a ₹2 final dividend and the relocation of its registered office to Haryana during the meeting held on July 30, 2026. The company also re-appointed Anil Kumar Bhatnagar as a director and ratified auditor remuneration, with all resolutions passing with high voter support.
26Jul 26
NCLT adjourns BRS Capital petitions against Max Healthcare's Kalinga Hospital to Aug 4
Max Healthcare Institute Ltd. reported that the National Company Law Tribunal (NCLT), Cuttack Bench, has deferred the next hearing on petitions filed by BRS Capital Two Pte. Limited against its subsidiary, Kalinga Hospital Ltd., to August 4, 2026. The petitions also name Max Healthcare Institute and another shareholder from whom the majority equity stake was acquired. No settlement has been reached, and the filing was made under Regulation 30 of SEBI LODR Regulations.
10Jul 26
Max Healthcare Institute to host investor meet on July 14
Max Healthcare Institute Ltd is set to conduct a group investor meeting in Delhi on July 14, 2026, organized by Kotak Securities Limited. The physical meeting serves as a platform for the company to engage with the investment community.
10Jul 26
Max Healthcare Institute publishes notice for 25th AGM
Max Healthcare Institute Ltd published the notice for its 25th Annual General Meeting and e-voting information in the Business Standard and Navshakti newspapers on July 9, 2026.
09Jul 26
Max Healthcare Sees ₹77.61 Crore Block Trade on BSE at ₹1108 Per Share
A block trade worth ₹77.61 crore was executed on BSE for Max Healthcare, involving approximately 700445 shares at a price of ₹1108 per share. The transaction represents a significant institutional-level deal in the counter. The trade was carried out on the BSE platform.
09Jul 26
NCLT adjourns Max Healthcare subsidiary Kalinga Hospital hearing to July 23
NCLT Cuttack adjourned the hearing on petitions involving Max Healthcare Institute Ltd and its subsidiary Kalinga Hospital Ltd to July 23, 2026. The hearing concerns an interlocutory petition by BRS Capital Two Pte. Limited seeking a stay on Kalinga Hospital's Postal Ballot Notice regarding increased borrowing limits.
02Jul 26
Max Healthcare reclassifies Radiant Life Care to Public category
Max Healthcare Institute secured regulatory approval from BSE and NSE to reclassify Radiant Life Care Hospital Foundation from the Promoter Group to the Public category effective July 1, 2026. The move follows an application dated May 24, 2026, under Regulation 31A of the SEBI (LODR) Regulations, 2015.
01Jul 26
Max Healthcare acquires 100% Class A shares in YPPL
Max Healthcare Institute Ltd has acquired 100% of the Class A equity shares in Yerawada Properties Private Limited, securing full voting rights and ~50.22% economic interest, making YPPL a subsidiary. The acquisition, effective June 30, 2026, supports the development of a ~450 bedded super speciality hospital in Pune.
01Jul 26
Max Healthcare Institute penalised ₹32.81 lakh by Income Tax Department
Max Healthcare Institute received a penalty of ₹32.81 lakh from the Income Tax Department for transactions adjusted via journal entries against receivables. The authority deemed these entries as loan or deposit repayments through non-prescribed modes. The company stated there is no material impact beyond the penalty and is filing an appeal.
30Jun 26
Max Healthcare Institute sets July 3 record date for ₹2 dividend
Max Healthcare Institute announced a final dividend of ₹2 per share for FY26, with July 3, 2026, as the record date. The 25th AGM is scheduled for July 30, 2026, via VC/OAVM, subject to shareholder approval.
20Jun 26
Max Healthcare fixes July 3 record date for Rs 2 dividend
Max Healthcare Institute Ltd has fixed July 3, 2026, as the record date to determine eligibility for a final dividend of Rs 2 per equity share, recommended by the board on May 21, 2026. The payout is subject to approval at the Annual General Meeting on July 30, 2026. The company detailed the tax deduction at source (TDS) rates under the Income-tax Act, 2025, specifying exemptions for resident shareholders with dividends under Rs 10,000 and variable rates for non-residents based on Tax Treaty benefits. Members must submit necessary documentation to the registrar by July 10, 2026, to ensure appropriate tax deduction.
18Jun 26
Max Healthcare CMD to attend IIFL conference in London
Max Healthcare Institute Limited disclosed that its Chairman and Managing Director will attend IIFL's Invest India Conference & Capital Day 2026 in London on June 23, 2026. The event will feature physical one-on-one and group meetings at Hotel Hilton, Paddington. The company confirmed no unpublished price sensitive information will be shared, and the schedule is subject to change.
18Jun 26
Citi Maintains Buy Rating on Max Healthcare Institute with Target Price of ₹1,240
Citi has maintained a Buy rating on Max Healthcare Institute with a target price of ₹1,240, citing an attractive entry point after an 18% stock correction. The brokerage projects a 20% EBITDA CAGR through FY26–30E, driven by new capacity additions and a strong balance sheet. Revenue acceleration is expected from FY27–28, supported by capacity ramp-up, oncology recovery, and a better payer mix. A reversal in CGHS oncology pricing has been flagged as additional upside optionality.
17Jun 26
Max Healthcare Institute Records ₹20.87 Crore Block Trade on NSE at ₹1025.50 Per Share
Max Healthcare Institute recorded a block trade on the NSE involving approximately 203,520 shares at a price of ₹1025.50 per share. The total value of the transaction amounted to ₹20.87 crores. Block trades of this scale are typically associated with institutional-level transactions and are closely tracked by market participants for insights into large-volume activity.
10Jun 26
Max Healthcare CMD to attend Kotak investor conference in London
Max Healthcare Institute Limited disclosed that its Chairman and Managing Director will participate in the Kotak India Corporate Day 2026 on June 15, 2026, at the InterContinental London. The event will feature physical one-on-one and group meetings, with no unpublished price sensitive information scheduled for release. The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
06Jun 26
Max Healthcare promoters disclose no share encumbrance in FY26
Promoters Abhay Soi and Aditya Soi confirmed that no shares of Max Healthcare Institute Limited were encumbered directly or indirectly during the financial year 2025-26. The disclosure was submitted to the stock exchanges under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
30May 26
Max Healthcare FY26 PAT rises 22% to INR 1,631 crore
Max Healthcare Institute Limited announced its financial results for the quarter and year ended March 31, 2026, reporting a 22% increase in full-year PAT to INR 1,631 crore. Revenue grew by 16% year-on-year to INR 10,538 crore, while Q4 revenue reached INR 2,664 crore. The company highlighted operational metrics including over 75% occupancy and significant contributions from digital and international patient segments. Strategic developments included the acquisition of Kalinga Hospital and approval for a new INR 1,400 crore hospital in Lucknow.
29May 26
Max Healthcare schedules investor conferences with Citi and Jefferies
Max Healthcare Institute Limited announced its participation in investor conferences with Citi and Jefferies in June 2026. The events include Citi's 2026 India Conference in Mumbai and Jefferies India Access Day 2026 in New York. The company confirmed that no unpublished price sensitive information will be shared during these meetings.
27May 26
Max Healthcare reports FY26 net revenue of ₹10,065 crore
Max Healthcare Institute Limited reported a net revenue of ₹10,065 crore for FY26, a 16% year-on-year growth, driven by strong operational performance and acquisitions. Profit after tax increased 22% to ₹1,631 crore, while operating EBITDA rose 14% to ₹2,638 crore, maintaining a margin of 26.2%. The company plans to add 4,000 beds over the next 3-4 years and recently commissioned new towers in Mohali, Mumbai, and Saket.
25May 26
Max Healthcare seeks re-classification of entity to public category
Max Healthcare Institute Limited applied to BSE and NSE on May 24, 2026, to reclassify Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category under SEBI regulations, following Board approval.
23May 26
Max Healthcare Q4 Net Profit Rises to 3.4b Rupees
Max Healthcare Institute Limited reported a consolidated net profit of 3.4b Rupees for Q4 FY26, up from 3.2b Rupees YoY. Revenue rose to 21.4b Rupees, and the board recommended a final dividend of ₹2 per share.
23May 26
CCI closes Max Healthcare abuse of dominance case
Max Healthcare Institute announced that the Competition Commission of India (CCI) has passed separate orders on May 21, 2026, in favour of its network hospitals, dismissing allegations of abuse of dominant position. The CCI rejected the Director General's findings following a supplementary investigation, concluding that no case under Section 4 of the Competition Act, 2002 was established. The orders close the proceedings initiated in 2018 regarding pricing practices, with no adverse impact on the company.
22May 26
Max Healthcare Plans Major Expansion With 3,500 New Beds Over Three Years: Conference Call Update
Max Healthcare has unveiled plans to add 3,500 new beds over a three-year period, as announced during a recent conference call update. The expansion reflects the company's strategic focus on scaling its healthcare infrastructure. No additional financial metrics or facility-specific details were included in the source data.
22May 26
Max Healthcare Institute Records ₹32.88 Crore Block Trade on NSE at ₹1026.50 Per Share
Max Healthcare Institute recorded a block trade on the NSE valued at ₹32.88 crores, involving approximately 320,314 shares at a price of ₹1026.50 per share. Such large-lot transactions are typically associated with institutional participation and are executed to minimise market impact. The trade highlights notable activity in the Max Healthcare Institute counter on the NSE.
21May 26
Max Healthcare grants 2.15L stock options under ESOP 2022
Max Healthcare Institute Limited has granted 2,15,000 stock options to eligible employees under its ESOP 2022 scheme, split into two tranches of 90,000 and 1,25,000 options. The options have exercise prices of ₹350 and ₹800 respectively, with a vesting period of 1-5 years and a 3-year exercise window.
20May 26
Max Healthcare faces NCLT petition from BRS Capital
Max Healthcare Institute Limited reported that BRS Capital Two Pte. Limited filed a petition before the NCLT, Cuttack Bench, alleging oppression and mismanagement of Kalinga Hospital Ltd. The tribunal has reserved the matter for orders after hearing submissions, with the next hearing set for July 7, 2026. The company noted that the financial impact of the petition cannot be anticipated at this stage.
19May 26
Max Healthcare Acquires ~58.28% Stake in Kalinga Hospital for ~₹297.97 Crore
Max Healthcare Institute Limited completed the acquisition of a ~58.28% controlling equity stake in Kalinga Hospital Ltd (KHL) for ~₹297.97 Crore on May 18, 2026, financed through a Senior Secured Term Loan of up to ₹300 Crore via External Commercial Borrowings. KHL, which operates a 250-bed multi-specialty hospital in Bhubaneswar, Odisha, has become a subsidiary of Max Healthcare Institute Limited following the transaction.
15May 26
Max Healthcare Institute Shareholders Approve Re-appointment of Narayan K. Seshadri via Postal Ballot
Max Healthcare Institute Limited completed its postal ballot process on May 11, 2026, with shareholders approving the re-appointment of Mr. Narayan K. Seshadri as Non-Executive and Non-Independent Director for a three-year term from May 16, 2026 to May 15, 2029. The resolution secured ~91.07% votes in favour out of 87,53,79,499 total votes polled, representing 89.95% of the total eligible share capital of 97,31,92,502 equity shares. The minutes were signed on May 14, 2026 at New Delhi, with results communicated to stock exchanges and hosted on the Company's website.
14May 26
Max Healthcare Institute Receives Reclassification Request from Radiant Life Care Hospital Foundation
Max Healthcare Institute Limited received a formal request on May 12, 2026, from Radiant Life Care Hospital Foundation (RLCHF) to reclassify from 'Promoter Group' to 'Public' category under Regulation 31A of SEBI (LODR) Regulations, 2015. The request was triggered by the sale of the entire equity stake held by Mr. Abhay Soi and Radiant Life Care Private Limited in RLCHF. Since RLCHF holds nil shares in the company, the reclassification will have no impact on the overall promoter and promoter group shareholding.
02May 26
Max Healthcare Institute Allots 51,287 Equity Shares Under Employee Stock Option Scheme
Max Healthcare Institute Limited's Nomination & Remuneration Committee approved the allotment of 51,287 equity shares under Employee Stock Option Scheme 2022 on May 1, 2026. The shares were issued at ₹350 per share with ₹340 premium to eligible employees, increasing the company's paid-up equity capital from ₹973,19,25,020 to ₹973,24,37,890. The allotment complies with SEBI regulations and detailed filing information has been submitted to BSE and NSE.
22Apr 26
Max Healthcare Institute Receives GST Rectification Order Withdrawing ₹55.20 Crore Demand
Max Healthcare Institute Limited received a GST rectification order on April 21, 2026, withdrawing the entire demand of ₹55,20,45,266 that was raised for alleged excess Input Tax Credit availment. The order was issued by the GST Officer, Ward 96, Zone 9, Department of Trade and Taxes, New Delhi, following the company's rectification application. This positive development reverses the earlier GST demand that was communicated by the company on December 30, 2025, and has been disclosed under SEBI Regulation 30 requirements.
21Apr 26
HSBC Maintains Buy Rating on Max Healthcare Institute with ₹1,125 Target Price
HSBC maintains Buy rating on Max Healthcare Institute with ₹1,125 target price for Q4FY26. The brokerage expects steady performance driven by pickup in elective procedures, continued capex-led expansion, and sustained healthy operating trends across hospital business, with manageable new unit margin drag.
17Apr 26
Max Healthcare Revises Expansion: 1,200 Beds by FY27 for 6,500 Total Capacity
Max Healthcare Institute has updated its expansion strategy with Co MD announcing plans to add 1,200 hospital beds by FY27, aiming for total capacity of approximately 6,500 beds. This represents a more measured approach compared to the chairman's earlier announcement of exceeding 10,000 beds within 24 months, indicating strategic recalibration toward sustainable growth targets.
12Apr 26
Max Healthcare Publishes Postal Ballot Notice for Director Re-appointment
Max Healthcare Institute has published its postal ballot notice in newspapers on April 12, 2026, seeking shareholder approval for re-appointing Mr. Narayan K. Seshadri as Non-Executive Director for three years. The e-voting process runs from April 12-May 11, 2026, with results expected by May 13, 2026.
10Apr 26
Max Healthcare Institute Executes Rs. 61.00 Crore Block Trade on NSE
Max Healthcare Institute Limited completed a significant NSE block trade worth Rs. 61.00 crores, involving approximately 640,842 shares at Rs. 951.80 per share. The transaction represents substantial institutional activity and demonstrates continued investor interest in the healthcare company's stock through large-volume trading mechanisms.
09Apr 26
Goldman Sachs Maintains Buy Rating on Max Healthcare with ₹1,300 Target Price
Goldman Sachs maintains its Buy rating on Max Healthcare Institute with a ₹1,300 target price, citing growth potential from strategic market expansion. The investment bank highlighted the company's entry into the underserved Bhubaneswar market, limited local competition within 5km radius, and strategic location selection as key growth drivers. Goldman Sachs emphasized that Max Healthcare's acquisition-led expansion strategy supports long-term growth visibility and strengthens the company's market positioning.
08Apr 26
Max Healthcare Institute Executes Rs. 49.05 Crore Block Trade on NSE
Max Healthcare Institute Ltd. completed a block trade worth Rs. 49.05 crores on NSE, involving approximately 518,926 shares at Rs. 945.15 per share. The transaction represents significant institutional activity and demonstrates substantial liquidity in the company's shares.
08Apr 26
Max Healthcare Institute Files Regulatory Certificate for Quarter Ended March 31, 2026
Max Healthcare Institute Limited filed a regulatory certificate confirming no dematerialization requests were received during the quarter ended March 31, 2026. The certificate, issued by registrar MUFG Intime India Private Limited, was submitted to stock exchanges as required under SEBI regulations. The company noted that all shares exist in electronic form with no physical certificates outstanding.
07Apr 26
Max Healthcare Institute Executes Rs. 16.16 Crore Block Trade on NSE
Max Healthcare Institute Limited completed a block trade on NSE valued at Rs. 16.16 crores for approximately 177,616 shares at Rs. 910.00 per share. The transaction demonstrates institutional investor participation and represents significant trading activity in the healthcare sector, typically reflecting portfolio adjustments or strategic investment decisions by large market participants.
01Apr 26
Max Healthcare Institute Allots 57,461 Equity Shares Under Employee Stock Option Scheme 2022
Max Healthcare Institute Limited allotted 57,461 equity shares under its Employee Stock Option Scheme 2022 on April 1, 2026, following NRC approval. The shares were issued at ₹350 per share with ₹340 premium to employees exercising vested options. This increased the company's total equity shares to 97,31,92,502 and paid-up capital to ₹973,19,25,020, with no lock-in restrictions on the newly allotted shares.
26Mar 26
Max Healthcare's Subsidiary ET Planners Private Limited Dissolved Following NCLT Order
Max Healthcare Institute Limited has completed the voluntary liquidation of its step-down subsidiary ET Planners Private Limited following an NCLT order on March 25, 2026. The liquidation process, initiated in September 2024, involved transferring the entire business undertaking worth Rs. 41,72,45,487 in creditor claims to Alps Hospital Limited on a going concern basis. The company has confirmed no material impact on its financials or business operations from this dissolution.
23Mar 26
Max Healthcare Institute Executes Rs. 20.43 Crore Block Trade on NSE
Max Healthcare Institute Ltd. completed a major NSE block trade involving 212,594 shares at Rs. 961.10 per share, generating Rs. 20.43 crores in transaction value. The block trade represents significant institutional trading activity and demonstrates market confidence in the healthcare provider at the current valuation levels.
23Mar 26
HSBC Upgrades Max Healthcare Institute to Buy with Target Price of Rs 1125
HSBC has upgraded Max Healthcare Institute to Buy rating with target price increased to Rs 1125 from Rs 1060. The upgrade is driven by strong growth visibility with 28.5% EPS CAGR projected for FY26-28, supported by 43% capacity addition of 2,240 beds through largely brownfield expansion. Scale benefits, ramp-up of Noida and Dwarka hospitals, and CGHS-driven occupancy are expected to offset near-term operational challenges.
18Mar 26
Jefferies Maintains Buy Rating on Max Healthcare with Rs 1,320 Target Price
Jefferies maintains Buy rating on Max Healthcare Institute with Rs 1,320 target price, citing resolution of December quarter one-off issues and expansion plans remaining on track. The brokerage noted that Delhi-NCR capacity addition is not a concern and highlighted the company's openness to selective acquisitions for market strengthening and expansion.
17Mar 26
Max Healthcare Allots 42,266 Equity Shares Under Employee Stock Option Scheme
Max Healthcare Institute Limited successfully allotted 42,266 equity shares to eligible employees under its Employee Stock Option Scheme 2022 following NRC approval on March 17, 2026. The shares were issued at ₹350 per share with a premium of ₹340, resulting in an increase of the company's paid-up equity share capital from ₹973.09 crore to ₹973.14 crore.
02Mar 26
Max Healthcare CMD to Participate in J.P. Morgan India Forum 2026 in Singapore
Max Healthcare Institute Limited announced that its Chairman and Managing Director will participate in the J.P. Morgan India Forum 2026 on March 9-10, 2026 at the Fullerton Hotel in Singapore. The forum will include both one-on-one and group meetings with investors, conducted in physical mode. The company has assured that no unpublished price sensitive information will be shared during the conference.
27Feb 26
Max Healthcare Institute Executes Rs. 22.14 Crore Block Trade on NSE
Max Healthcare Institute Ltd. completed a major NSE block trade involving approximately 202,072 shares at Rs. 1095.50 per share, totaling Rs. 22.14 crores. The transaction reflects significant institutional investor activity in the healthcare sector and provides insight into current valuation levels for the company's stock.
21Feb 26
Max Healthcare Institute Receives Partial Relief in GST Appeal, Demand Reduced to ₹1.77 Crore
Max Healthcare Institute Limited received partial relief in its GST appeal case, with the Commissioner of Central Tax Appeal-II, Delhi significantly reducing the original demand. The GST demand was reduced from ₹2.59 crore to ₹85.36 lakh, penalty from ₹2.53 crore to ₹85.36 lakh, and interest to ₹6.89 lakh. The company plans to file a further appeal for the remaining balance amount.
07Feb 26
Max Healthcare Institute Limited Announces Investor Presentations for February 2026 Conferences
Max Healthcare Institute Limited announced its participation in two major investor conferences in February 2026 - the Nuvama India Conference on February 9 and the 17th Kotak Chasing Growth Conference on February 23. The announcement was made under Regulation 30 compliance and communicated to NSE and BSE on February 7, 2026. As India's largest hospital chain by market cap, the company will use these platforms to engage with investors and analysts about its business performance and strategic initiatives.
06Feb 26
Max Healthcare Q3FY26: Consolidated PAT Up 26% to ₹301 Cr, Earnings Call Recording Now Available
Max Healthcare Institute delivered strong Q3FY26 results with consolidated profit after tax rising 26% to ₹301 Cr and revenue growing 11% to ₹2,068 Cr year-on-year. The company announced strategic expansion plans including 260 additional beds at Dwarka and a 450-bed hospital acquisition in Pune worth ₹1,020 Cr. The audio recording of the February 6, 2026 earnings call discussing these results is now available on the company website.
06Feb 26
Max Healthcare Secures Annual Price Revision Agreements with Insurance Companies
Max Healthcare Institute management confirmed during a conference call that the company has agreements in place with insurance companies for annual price revisions. These structured arrangements indicate systematic pricing mechanisms between the healthcare provider and its insurance partners, potentially offering greater predictability in revenue management and service pricing coordination.
04Feb 26
Max Healthcare Institute Grants 2,84,520 Stock Options to Eligible Employees Under ESOP 2022
Max Healthcare Institute Limited granted 2,84,520 stock options to eligible employees under its ESOP 2022 scheme on February 4, 2026. The grant includes 2,34,520 options at ₹900 per option and 50,000 options at ₹800 per option, with each option convertible to one equity share of ₹10 face value. The options vest between 1-5 years and can be exercised within 3 years of vesting, subject to NRC-determined conditions.
29Jan 26
Max Healthcare Institute Initiates Voluntary Liquidation of Nigeria Subsidiary
Max Healthcare Institute Limited announced the voluntary liquidation of its wholly-owned subsidiary MHC Global Healthcare (Nigeria) Limited on January 29, 2026. The Nigerian subsidiary had zero revenue and negative networth of ₹70,89,724 as of March 31, 2025, representing only (0.0076%) of consolidated financials. The company confirmed this liquidation will not impact business operations or materially affect consolidated financials.
28Jan 26
Max Healthcare Institute Schedules Board Meeting on February 5, 2026 for Q3FY26 Financial Results
Max Healthcare Institute Limited has scheduled its Board of Directors meeting for February 5, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company has notified both NSE and BSE in compliance with SEBI Regulation 29, while maintaining trading window closure for designated persons until 48 hours after results declaration. The disclosure will be made available on the company's official website, ensuring comprehensive stakeholder communication.
20Jan 26
Max Healthcare Institute Executes ₹64.66 Crore Block Trade on NSE
Max Healthcare Institute Limited completed a major block trade on NSE worth ₹64.66 crores, involving 645,871 shares at ₹1,001.10 per share. The transaction reflects institutional activity and demonstrates continued investor interest in the healthcare sector leader.
09Jan 26
Macquarie Raises Max Healthcare Institute Target Price to ₹825, Maintains Underperform Rating
Macquarie has raised its target price for Max Healthcare Institute to ₹825 from ₹615, representing a 34% increase, while maintaining its Underperform rating. This revision reflects improved valuation metrics despite ongoing concerns about the stock's relative market performance.
07Jan 26
Max Healthcare Institute Executes ₹15.59 Crore Block Trade on NSE
Max Healthcare Institute Ltd. completed a block trade worth ₹15.59 crores on NSE, involving approximately 151,175 shares at ₹1,031.40 per share. The transaction represents significant institutional activity in the healthcare sector.
02Jan 26
Max Healthcare Institute Allots 2.32 Lakh Equity Shares Under ESOP 2022 Scheme
Max Healthcare Institute Limited completed an equity share allotment under its Employee Stock Option Scheme 2022, issuing 2,32,104 shares to eligible employees at two different exercise prices. The allotment increased the company's paid-up capital to ₹973.00 crores and demonstrates the organization's commitment to employee participation in corporate growth through structured stock option programs.
31Dec 25
Max Healthcare Faces ₹55.20 Crore GST Claim for Possible Excess Input Tax Credit
Max Healthcare Institute faces a ₹55.20 crore GST claim from authorities regarding possible excess input tax credit. The company has responded by initiating both rectification and appeal processes to address this significant tax matter, demonstrating a proactive approach to regulatory compliance challenges.
30Dec 25
Max Healthcare receives ₹55 crore GST demand from Delhi authorities amid strong Q2 performance
Max Healthcare Institute received a ₹55.20 crore GST demand from Delhi authorities for alleged excess Input Tax Credit availment, comprising ₹33.66 crore in demand, ₹18.18 crore in interest, and ₹3.37 crore in penalty. The company is seeking rectification and may appeal if necessary. Despite regulatory challenges, Max Healthcare reported strong Q2 FY26 results with net profit jumping 74.3% to ₹491 crore and revenue growing 25% to ₹2,135 crore, driven by increased OPD visits and robust international patient revenue growth of 25% year-on-year.
30Dec 25
Max Healthcare Faces ₹55.2 Cr GST Demand in Fresh Order from Delhi Authorities
Max Healthcare Institute Limited has received a fresh GST demand order totaling ₹55.20 crores from Delhi tax authorities on December 30, 2025, for alleged excess Input Tax Credit availment. Combined with a previous GST order of ₹12.73 crores, the company now faces potential cumulative liabilities exceeding ₹67 crores and plans to seek rectification with possible appeals.
19Dec 25
Goldman Sachs Issues Buy Rating on Max Healthcare with Target Price of ₹1,325
Goldman Sachs has given a Buy rating to Max Healthcare Institute, a large-cap healthcare provider, with a target price of ₹1,325.00 per share. This recommendation reflects Goldman Sachs' positive outlook on the company's investment prospects and potential stock performance.
19Dec 25
Max Healthcare Plans Over ₹1,000 Crore Investment for New Pune Hospital
Max Healthcare Institute has announced a significant expansion with an investment of over ₹1,000 crores (₹10 billion) for developing a new hospital facility in Pune. This major capital commitment represents one of the larger healthcare infrastructure investments in the region and aligns with the company's broader strategy to strengthen its presence in key metropolitan markets across India, particularly enhancing healthcare services in Maharashtra.
18Dec 25
Max Healthcare Board Approves ₹1,020 Cr Yerawada Properties Acquisition Deal
Max Healthcare Institute's board has approved a comprehensive ₹1,020 crore investment plan involving the complete acquisition of Yerawada Properties Private Limited and development of a 450-bed super specialty hospital in Pune. The acquisition will be executed in phases over 4 years, with the first tranche involving 100% Class A equity shares providing full voting rights and 50.22% economic interest, followed by gradual acquisition of Class B shares.
21Nov 25
Max Healthcare Reports Robust Q2 FY26 Results with 21% Revenue Growth
Max Healthcare Institute Limited announced robust Q2 FY26 results, with revenue up 21% to ₹2,692 crore and net profit soaring 74.34% to ₹491.30 crore. The company's EBITDA margin improved to 26.93%. Expansion initiatives include new towers at Max Mohali, Nanavati-Max, and Max Smart, adding significant bed capacity. The company expects to benefit from CGHS price revisions, potentially adding over ₹200 crore to revenue once fully implemented.
18Nov 25
Max Healthcare Sees Rs. 92.97 Crore Block Trade on NSE
Max Healthcare Institute witnessed a significant block trade on the National Stock Exchange (NSE), involving 832,909 shares at Rs. 1,116.20 per share, totaling Rs. 92.97 crores. The company operates 20 healthcare facilities with about 5,200 beds, mainly in North India. Max Healthcare is set to participate in two upcoming investor conferences: CLSA 28th India Forum and Goldman Sachs 14th India CIO Tour.
18Nov 25
Max Healthcare Unveils Ambitious Plan to Add Over 8,300 Hospital Beds
Max Healthcare Institute Limited plans to add over 8,300 hospital beds to its network, with 4,800 beds expected to be operational within 3-4 years. The company currently operates 20 facilities with 5,200 beds. Ongoing projects include expansions in Mumbai, Delhi, Gurugram, and Mohali. This move aims to meet growing healthcare demands across India and strengthen the company's market position.
17Nov 25
Max Healthcare Anticipates Rs 200 Crore Boost from Revised CGS Norms
Max Healthcare Institute expects a favorable financial impact of Rs 200.00 crore from upcoming revised Cash Generating Schemes (CGS) norms, as announced during a recent conference call. This anticipated benefit could significantly strengthen the company's financial position in the healthcare sector. The company recently published its financial results in Financial Express and Navshakti newspapers on November 16, 2025, demonstrating transparency and regulatory compliance.
15Nov 25
Max Healthcare Reports 74% Profit Surge, Driven by Outpatient and International Revenue Growth
Max Healthcare Institute posted strong Q2 FY2024 results with net profit rising 74.3% year-on-year to ₹491 crore and revenue increasing 25% to ₹2,135 crore. The company maintained a robust EBITDA margin of 26.9%. Growth was driven by increased outpatient visits and higher international patient revenue. Despite expansion efforts, net debt rose to ₹2,067 crore.
07Nov 25
Max Healthcare's ESG Score Improves to 75.1 for FY2024-25
Max Healthcare Institute Limited received an improved ESG score of 75.10 for FY 2024-25, up from 73.70 in FY 2023-24. The assessment was independently conducted by SES ESG Research Private Limited, a SEBI-registered ESG Rating Provider, based on public disclosures. Max Healthcare promptly informed stock exchanges of this development, adhering to regulatory requirements.
31Oct 25
Max Healthcare Institute Executes Rs. 59.23 Crore Block Trade on NSE
Max Healthcare Institute conducted a significant block trade on the National Stock Exchange (NSE). The transaction involved approximately 513,125 shares, valued at Rs. 59.23 crores, with each share priced at Rs. 1154.30. This substantial trade may indicate significant investor interest or a strategic move by a large shareholder, potentially impacting the company's market dynamics.
01Oct 25
Max Healthcare Institute Sees ₹129.13 Crore Block Trade on NSE
Max Healthcare Institute Ltd. experienced a significant block trade on the National Stock Exchange (NSE), involving 1,158,151 shares valued at ₹129.13 crore. The transaction was executed at ₹1,115.00 per share. Block trades often indicate institutional activity or major shareholder movements, potentially offering insights into investor sentiment and ownership changes.
25Sept 25
Max Healthcare Institute Sees Rs. 131.16 Crore Block Trade on NSE
Max Healthcare Institute Ltd. experienced a significant block trade on the National Stock Exchange (NSE), involving 1,151,919 shares valued at Rs. 131.16 crore. The transaction was executed at Rs. 1,138.60 per share, reflecting current market valuations. This substantial trade indicates ongoing interest in the healthcare sector among institutional investors.
23Sept 25
Max Healthcare Institute Sees Rs. 119.33 Crore Block Trade on NSE
Max Healthcare Institute Ltd. experienced a significant block trade on the NSE, involving 1,030,669 shares at Rs. 1,157.80 per share, totaling Rs. 119.33 crore. Separately, GIC Private Limited, representing the Government of Singapore and Monetary Authority of Singapore, reduced their combined shareholding to 5.81% of the company's total share capital.
22Sept 25
GIC Private Limited Trims Stake in Max Healthcare to 5.813%
GIC Private Limited, acting for the Government of Singapore (GOS) and Monetary Authority of Singapore (MAS), has sold 960,808 shares of Max Healthcare Institute Ltd. This reduced their combined stake from 5.912% to 5.813%. The Government of Singapore's stake decreased to 4.508%, while MAS's stake is now 1.305%. This sale triggered a disclosure under SEBI takeover regulations.
10Sept 25
Max Healthcare Institute Executes Rs. 15.96 Crore Block Trade on NSE
Max Healthcare Institute Ltd. executed a significant block trade on the National Stock Exchange (NSE), involving 136,504 shares at Rs. 1,169.30 per share, totaling Rs. 15.96 crore. This transaction highlights the ongoing interest in the company's stock among large investors and could potentially impact market sentiment.
14Aug 25
Max Healthcare Institute Sees Block Trade Worth Rs. 101.05 Crores on NSE
A significant block trade of 827,282 shares of Max Healthcare Institute Ltd. occurred on the National Stock Exchange (NSE), valued at Rs. 101.05 crores. The shares were traded at Rs. 1,221.50 per share. This transaction highlights ongoing interest in the healthcare sector and Max Healthcare Institute specifically. The identities of the parties involved in the trade were not disclosed.
14Aug 25
Max Healthcare Reports 27% Revenue Growth in Q1, Driven by Strong Patient Volumes
Max Healthcare Institute Limited reported robust Q1 financial results. Gross revenue increased 27% year-on-year to ₹2,574.00 crore, driven by a 26% rise in occupied bed days. Operating EBITDA grew 23% to ₹613.00 crore, with a 24.9% margin. Profit after tax rose 17% to ₹345.00 crore. The company saw improvements in bed occupancy, outpatient consultations, and international patient revenue. Max Healthcare continues its expansion with new hospital projects and strategic initiatives in non-hospital businesses.
13Aug 25
Max Healthcare Expands with New Hospital in Dehradun, Reports Strong Q1 Performance
Max Healthcare Institute plans to set up a new 130-bed hospital in Dehradun, focusing on advanced oncology services. The company reported robust Q1 financial results with revenue growing 31.4% YoY to ₹2,027.57 crore, EBITDA increasing 35.1% to ₹523.00 crore, and net profit rising 30.3% to ₹307.97 crore. Other developments include progress on subsidiary mergers, land acquisition for hospital expansion in Ghaziabad, divestment of hospitals in Bulandshahr, and allotment of shares under ESOP.
07Aug 25
Max Healthcare Institute Sees Rs. 50.66 Crore Block Trade on NSE
Max Healthcare Institute witnessed a significant block trade on NSE, with 403,231 shares changing hands at Rs. 1256.30 per share, totaling Rs. 50.66 crores. The company has scheduled its Q1 financial results announcement for August 13, followed by an earnings call on August 14 at 12:30 PM IST. Max Healthcare operates 22 healthcare facilities with over 5,100 beds, primarily in North India.
16Jul 25
Max Healthcare Engages in Discussions on Nationwide Unified Treatment Rates
Max Healthcare Institute Ltd is reportedly participating in discussions about implementing unified treatment rates across India. This initiative could lead to standardized healthcare costs nationwide, potentially improving transparency and accessibility in the healthcare sector. The move may face challenges in addressing regional cost variations and maintaining service quality. The outcome could significantly impact the healthcare industry's competitive landscape and pricing strategies.
12Jul 25
Max Healthcare Completes Sale of Stake in Sandhya Hydro Power Project
Max Healthcare Institute has completed the sale of 12,84,396 equity shares in the Sandhya Hydro Power Project to Skyzen Infrabuild Private Limited. The transaction occurred on July 11, 2025, following the termination of a power purchase agreement and board approval on May 20, 2025. This move aligns with Max Healthcare's strategy to focus on its core healthcare business.
30May 25
Max Healthcare Institute Shares: Major Block Trade Worth ₹55.26 Crore on NSE
A substantial block trade of 485,998 shares of Max Healthcare Institute Ltd. occurred on the National Stock Exchange (NSE) at a price of ₹1,137.00 per share, totaling ₹55.26 crore. This significant transaction suggests a notable shift in ownership for the company, which is a prominent player in India's healthcare sector. The identities of the buyer and seller were not disclosed.
22May 25
Max Healthcare Institute Unveils Ambitious Expansion Plan to Boost Capacity by 30%
Max Healthcare Institute has announced a significant expansion plan to increase its bed capacity from 6,500 to 9,000 by 2028. The company aims to add 1,500 beds in FY26, representing a 30% increase. A capex budget of Rs 5,000 crore has been allocated for FY26-FY28 to support this growth, primarily through brownfield projects. While focusing on organic growth, Max Healthcare remains open to acquisitions and expects continued revenue growth per bed.
20May 25
Max Healthcare Institute: Q4 Profit Surges 21%, Dividend Announced
Max Healthcare Institute has reported strong Q4 results with a 21% increase in profit after tax to ₹376.00 crore and a 29% growth in network gross revenue to ₹2,429.00 crore. The company announced a final dividend of ₹1.50 per share. Strategic expansion plans include land acquisition for hospital expansion and upcoming operations in three new brownfield towers.
15May 25
Max Healthcare Institute Shares See Significant Block Trade on NSE
A significant block trade of 449,617 shares of Max Healthcare Institute Ltd. was executed on the National Stock Exchange at ₹1,197.00 per share, totaling ₹53.82 crore. This large transaction suggests potential institutional activity or strategic moves by major investors, and could impact market sentiment, ownership structure, and demonstrate stock liquidity.
07May 25
Max Healthcare Refutes Reports of Bidding for Sahyadri Hospital
Max Healthcare Institute Ltd. (MHIL) has officially denied involvement in any bidding process for the acquisition of Sahyadri Hospital, countering recent media reports. The company issued a clarification to address speculation and ensure accurate information is available to stakeholders and the public.
06May 25
Max Healthcare Refutes Reports of Bidding for Sahyadri Hospital
Max Healthcare Institute Ltd (MHIL) has issued a clarification denying recent media reports about its alleged involvement in the acquisition of Sahyadri Hospital. The company explicitly stated that it is not participating in any bidding process for the acquisition, aiming to dispel rumors and provide transparency to stakeholders.
06May 25
Max Healthcare Institute Sees Significant Block Trade on NSE
A block trade of 207,749 shares of Max Healthcare Institute Ltd. was executed on the NSE at Rs. 1,165.80 per share, totaling Rs. 24.22 crores. This transaction indicates potential institutional investor activity or changes in major shareholdings, though the identities of the buyer and seller remain undisclosed.
29Apr 25
Max Healthcare Institute Unveils Ambitious Rs 6,000 Crore Expansion Plan
Max Healthcare Institute has announced plans to invest Rs 6,000 crore by 2028 to add 3,700 new beds across India. The expansion will increase their network from 22 to approximately 30 hospitals, with new facilities in Dwarka, Mohali, Mumbai, and Saket. The investment will be entirely funded through internal profit reinvestment, showcasing the company's strong financial position. This expansion is expected to increase healthcare accessibility, create jobs, and enhance India's overall healthcare infrastructure.
Industry Peers
Apollo HospitalsMax Healthcare Institute
Fortis Healthcare
Aster DM Quality Care
Narayana Hrudayalaya
Global Health
Krishna Institute of Medical Sciences
Dr. Agarwal's Health Care
Rainbow Childrens Medicare
Park Medi World
8,660.00
(-0.48%)
986.40
(-0.41%)
905.20
(-1.39%)
765.25
(+1.91%)
1,870.90
(+0.60%)
1,399.90
(-0.40%)
776.85
(+1.37%)
495.85
(-0.39%)
1,446.00
(-0.97%)
281.55
(+0.54%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
